Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration

Abstract Background Lymphatic filariasis (LF) control in most countries of sub-Saharan Africa is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. However, attaining and maintaining high treatment coverage has been a...

Full description

Bibliographic Details
Published in:	Parasites & Vectors
Main Authors:	Yahya A. Derua, William N. Kisinza, Paul E. Simonsen
Format:	Article
Language:	English
Published:	BMC 2018-07-01
Subjects:	Lymphatic filariasis Microfilaraemia Circulating filarial antigens Hydrocele Elephantiasis Questionnaire
Online Access:	http://link.springer.com/article/10.1186/s13071-018-2999-x

Similar Items

Detection of anti-filarial antibody among hydrocele patients living in an endemic area for filariasis
by: Amit Kumar Singh, et al.
Published: (2016-01-01)

Ghana’s path towards eliminating lymphatic filariasis
by: Munawar Harun Koray
Published: (2024-05-01)

Hydrocele fluid: Can it be used for immunodiagnosis of lymphatic filariasis?
by: S. Mishra, et al.
Published: (2014-08-01)

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study
by: Adam M. Fimbo, et al.
Published: (2024-06-01)

Sero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August–September 2018
by: Vicent Mwesigye, et al.
Published: (2024-05-01)

Identification and control of an isolated, but intense focus of lymphatic filariasis on Satawal Island, Federated States of Micronesia, in 2003
by: Moses Pretrick, et al.
Published: (2017-06-01)

Integrated mapping of lymphatic filariasis and podoconiosis: lessons learnt from Ethiopia
by: Heven Sime, et al.
Published: (2014-08-01)

Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
by: Paul E Simonsen, et al.
Published: (2014-11-01)

Comparing different lymphatic filariasis patient estimate approaches and results in Ethiopia
by: Belete Mengistu, et al.
Published: (2024-02-01)

Use of digital assessment tools to measure health facility readiness to provide the WHO recommended package of care for lymphatic filariasis morbidity
by: Windtaré Roland Bougma, et al.
Published: (2024-12-01)

A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
by: Alice Halliday, et al.
Published: (2014-10-01)

Drug Repurposing of Bromodomain Inhibitors as Potential Novel Therapeutic Leads for Lymphatic Filariasis Guided by Multispecies Transcriptomics
by: Matthew Chung, et al.
Published: (2019-12-01)

Drug Repurposing of Bromodomain Inhibitors as Potential Novel Therapeutic Leads for Lymphatic Filariasis Guided by Multispecies Transcriptomics
by: Matthew Chung, et al.
Published: (2019-12-01)

Mapping lymphatic filariasis morbidities in 24 endemic districts of Ethiopia through the health extension program
by: Haileleuel Bisrat, et al.
Published: (2024-11-01)

Infectious etiologies of genital elephantiasis outside of filariasis endemic regions: a case report
by: Youssef Kharbach, et al.
Published: (2020-10-01)

Primary Retroperitoneal Filariasis Presenting with Acute Abdomen
by: Maram Z. Nached, et al.
Published: (2021-04-01)

Multiple filarial species microfilaraemia: a comparative study of areas with endemic and sporadic onchocerciasis
by: Emmanuel Uttah & Dominic C. Ibeh
Published: (2011-12-01)

Zambia: A Narrative Review of Success and Challenges in Lymphatic Filariasis Elimination
by: Kingford Chimfwembe, et al.
Published: (2024-01-01)

Prevalence of Lymphatic Filariasis based on Morbidity and Healthcare-seeking Practices of Patients in a Gram Panchayat of Paschim Burdwan District, West Bengal
by: Indranil Saha, et al.
Published: (2025-01-01)

Chiluria in a lymphatic filariasis endemic area
by: Paulo Sérgio Ramos de Araújo, et al.
Published: (2018-05-01)

Drug targets for lymphatic filariasis: A bioinformatics approach
by: Om Prakash Sharma, et al.
Published: (2013-08-01)

Surgical Intervention for Filariasis-Induced Lymphedema: A Systematic Review of Ablative and Physiological Approaches
by: Rani Septrina, et al.
Published: (2026-06-01)

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat
by: Kumar Pradeep, et al.
Published: (2008-01-01)

Mapping and modelling the impact of mass drug adminstration on filariasis prevalence in Myanmar
by: Ni Ni Aye, et al.
Published: (2018-05-01)

Evaluation of mass drug administration under the National Vector Borne Disease Control Program for lymphatic filariasis elimination in rural area of Telangana: A community-based cross-sectional study
by: Ratna Balaraju, et al.
Published: (2025-04-01)

Epidemiology of lymphatic filariasis with special reference to urogenital-manifestations
by: S P Pani, et al.
Published: (2005-01-01)

A large filarial hydrocele in Kenya: a case report
by: Charles Waihenya, et al.
Published: (2024-11-01)

Scrotal Lymphangiectasia with Penile Elephantiasis in Underlying Lymphatic Filariasis—Challenging the Diagnostic Mind! A Case Report
by: Tejas Vishwanath, et al.
Published: (2021-01-01)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
by: T S Ranganath, et al.
Published: (2012-01-01)

Editorial: Morbidity management of lymphatic filariasis: a focus on filarial hydrocele and lymphoedema
by: Sunny Doodu Mante, et al.
Published: (2025-05-01)

The Nodovenous Shunt and Reduction Surgery for Post-Filarial Lymphedema—Surgical Technique and Clinical Outcomes
by: Jonathan Victor, et al.
Published: (2021-01-01)

Mosquitoes and the Lymphatic Filarial Parasites: Research Trends and Budding Roadmaps to Future Disease Eradication
by: Damilare O. Famakinde
Published: (2018-01-01)

POST MASS DRUG ADMINISTRATION ASSESSMENT OF COVERAGE, COMPLIANCE, AND OBSTACLES IN A LYMPHATIC FILARIASIS ENDEMIC DISTRICT OF CENTRAL INDIA.
by: Neelam Anupama Toppo, et al.
Published: (2023-03-01)

Leaving no one behind: hernia, a neglected surgical condition identified during hydrocele surgery camps in Tanzania
by: Kelly Zongo, et al.
Published: (2024-04-01)

Correlated prevalence of hydrocele and microfilaremia in Amazon (Belém, 1951-2005)
by: Dilma Costa de Oliveira Neves, et al.
Published: (2021-01-01)

PREVALENCE OF AEROBIC BACTERIA CAUSING WOUND INFECTION IN PATIENTS WITH FILARIAL ELEPHANTIASIS IN A TERTIARY CARE HOSPITAL OF KOLKATA, INDIA
by: Bhakti Pada Barman, et al.
Published: (2022-08-01)

HRAMS Proteomics Insights on the Anti-Filarial Effect of <i>Ocimum sanctum</i>: Implications in Phytochemical-Based Drug-Targeting and Designing
by: Ayushi Mishra, et al.
Published: (2024-12-01)

An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa
by: Dziedzom Komi de Souza, et al.
Published: (2017-05-01)

Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets
by: Clarer Jones, et al.
Published: (2017-08-01)

Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa
by: Patricia M. Graves, et al.
Published: (2021-04-01)